Warning
SpecGx Recalls Oxycodone and Acetaminophen CII Tablets USP
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0255-2026Drug / Pharmaceutical
SpecGx Recalls Oxycodone and Acetaminophen CII Tablets USP
SpecGx, LLC · Class II — Moderate Risk
Product Description
Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0522-01. Case label: SpecGx LLC, NDC 0406052201, Exp. 2027/03, Lot: 0522J23493
Reason for Recall
Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
Nationwide
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
Sources: FDA openFDA Enforcement Database